MCF Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$420K Buy
1,962
+416
+27% +$93K 0.02% 283
2025
Q4
$265K Buy
1,546
+60
+4% +$9.33K 0.01% 263
2025
Q3
$199K Buy
1,486
+37
+3% +$3.92K 0.01% 247
2025
Q2
$141K Buy
1,449
+1,249
+625% +$99.1K 0.01% 272
2025
Q1
$14.6K Sell
200
-50
-20% -$3.94K ﹤0.01% 601
2024
Q4
$18.1K Hold
250
﹤0.01% 575
2024
Q3
$20.4K Hold
250
﹤0.01% 551
2024
Q2
$26.7K Hold
250
﹤0.01% 483
2024
Q1
$24.3K Sell
250
-230
-48% -$20.2K ﹤0.01% 497
2023
Q4
$37.7K Buy
480
+430
+860% +$29.3K ﹤0.01% 411
2023
Q3
$3.13K Hold
50
﹤0.01% 719
2023
Q2
$3.21K Hold
50
﹤0.01% 669
2023
Q1
$2.65K Hold
50
﹤0.01% 675
2022
Q4
$2.1K Buy
+50
New +$2.09K ﹤0.01% 675
2021
Q4
Sell
-30
Closed -$2K 412
2021
Q3
$2K Buy
+30
New +$1.82K ﹤0.01% 623
2016
Q3
Sell
-1,000
Closed -$8K 491
2016
Q2
$8K Sell
1,000
-2,000
-67% -$16.1K ﹤0.01% 364
2016
Q1
$25K Buy
3,000
+10
+0.3% +$73 0.01% 252
2015
Q4
$24K Buy
+2,990
New +$22.5K 0.01% 249
2015
Q2
Sell
-700
Closed -$5K 443
2015
Q1
$5K Hold
700
﹤0.01% 373
2014
Q4
$6K Hold
700
﹤0.01% 351
2014
Q3
$5K Buy
+700
New +$4.99K ﹤0.01% 375

Other funds holding LRCX

MCF Advisors's LRCX Position: Q1 2026 in Review

MCF Advisors increased its Lam Research (LRCX) stake by 27% in Q1 2026, buying an estimated $93K and bringing the position to 1,962 shares worth $420K. The position accounts for 0.02% of the portfolio, ranked #283.

MCF Advisors first reported a position in LRCX in Q3 2014 and has held it in 21 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • MCF Advisors held 1,962 shares of Lam Research worth $420K as of Q1 2026.
  • MCF Advisors bought 416 Lam Research shares in Q1 2026, an estimated $93K.
  • Lam Research made up 0.02% of MCF Advisors's portfolio in Q1 2026, its #283 holding.
  • MCF Advisors first reported a position in Lam Research in Q3 2014 and has held it in 21 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.